Nicholas Vogts
Physician Assistant · McPherson, KSNPI 1548726904
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 536 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 42 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,935 and has fallen 53.9% since, to $892 in 2025. Among physician assistant clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 536 payments — averaging $14.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$1K
- AstraZeneca$968
- Pfizer$911
- Amgen$807
- Novo Nordisk$436
- plus $2K from 36 others
What the payments were for
- Food & beverage$7,690100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,704 in reported general payments places this provider in the 95th percentile of 1,016 physician assistant providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 49 | $44,187 |
| OzempicSemaglutide | 39 | $34,269 |
| MounjaroTirzepatide | 17 | $24,604 |
| EliquisApixaban | 32 | $23,837 |
| Olmesartan Medoxomil | 47 | $1,048 |
| Tamsulosin Hcl | 109 | $909 |
| Ezetimibe | 17 | $833 |
| Tramadol Hcl | 54 | $626 |
| Colestipol Hcl | 14 | $551 |
| Atorvastatin Calcium | 119 | $510 |
| Digoxin | 15 | $483 |
| Famotidine | 39 | $469 |
| Gabapentin | 31 | $421 |
| Levothyroxine Sodium | 44 | $405 |
| Escitalopram Oxalate | 67 | $321 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $61 | $44,18749 claims |
| Novo NordiskOzempic | $436 | $34,26939 claims |
| Lilly USA, LLCMounjaro | $1,069 | $24,60417 claims |
| PfizerEliquis | $911 | $23,83732 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,016 physician assistant providers in Kansas.
Other physician assistant in McPherson
- Sierra FergusonWichita$25K
- Dylan TimmermannTopeka$19K
- Heather HowellKansas City$16K
- Amy BrettmanShawnee$14K
- Ashton YoungersWichita$14K
- Anthony GunawanLakin$13K
- Therese SchrandtWichita$13K
- Mike HallWichita$13K
- Melissa WilkesFort Riley$13K
- Jenny MartensWichita$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.